Cross-Checking between ED Physicians Reduces Harm
|
By HospiMedica International staff writers Posted on 08 May 2018 |

Image: A new study suggests a few minutes of consultation can avoid adverse ED events (Photo courtesy of Dreamstime).
A new study suggests that systematic cross-checking between doctors may be a key to reducing the high rate of adverse events in the emergency department (ED).
Researchers at the Sorbonne University (Paris, France), Pitie-Salpetriere Hospital (Paris, France), and other institutions conducted a cluster randomized crossover trial that included a random sample of 1,680 patients attended to in six EDs in France during two 10-day periods. The intervention included systematic cross-checking between ED physicians three times a day, which included a brief presentation of one physician’s case to another, followed by the second physician’s feedback. The main outcome was medical error, defined as either a near miss or a serious adverse event.
The results showed that there were 54 adverse events among 840 patients (6.4%) during the cross-check intervention, compared with 90 adverse events among 840 patients (10.7%) during the control period, a relative reduction of 40%. Most of the reductions occurred in adverse events defined as near misses, with a reduction of 47%. Errors in sepsis management accounted for more than 40% of the preventable serious adverse events. The median duration of cross-checking sessions was nine minutes, during which about seven patients were discussed. The study was published on April 23, 2018, in JAMA Internal Medicine.
“The reduction in preventable serious adverse events with systematic cross-checking did not reach statistical significance; only reductions in near misses did,” explained lead author Yonathan Freund, MD, PhD, of Hôpital Pitié-Salpêtrière. “Whether an adverse event resulted from a misdiagnosis or from the implementation of an inappropriate plan for the correct diagnosis could not be determined decisively. This included sepsis-associated medical errors, which may be particularly relevant, because the most commonly occurring serious adverse events were violations of the surviving sepsis campaign guidelines.”
An adverse event is defined as a preventable or non-preventable injury that was caused by medical management (rather than the underlying disease) and that prolonged hospitalization, produced a disability at the time of discharge, or both. Adverse event also include errors, defined as acts of commission or omission leading to an undesirable outcome or significant potential for such an outcome, and near misses, in which an error was committed, but the patient did not experience clinical harm, either through early detection or sheer luck.
Related Links:
Sorbonne University
Pitie-Salpetriere Hospital
Researchers at the Sorbonne University (Paris, France), Pitie-Salpetriere Hospital (Paris, France), and other institutions conducted a cluster randomized crossover trial that included a random sample of 1,680 patients attended to in six EDs in France during two 10-day periods. The intervention included systematic cross-checking between ED physicians three times a day, which included a brief presentation of one physician’s case to another, followed by the second physician’s feedback. The main outcome was medical error, defined as either a near miss or a serious adverse event.
The results showed that there were 54 adverse events among 840 patients (6.4%) during the cross-check intervention, compared with 90 adverse events among 840 patients (10.7%) during the control period, a relative reduction of 40%. Most of the reductions occurred in adverse events defined as near misses, with a reduction of 47%. Errors in sepsis management accounted for more than 40% of the preventable serious adverse events. The median duration of cross-checking sessions was nine minutes, during which about seven patients were discussed. The study was published on April 23, 2018, in JAMA Internal Medicine.
“The reduction in preventable serious adverse events with systematic cross-checking did not reach statistical significance; only reductions in near misses did,” explained lead author Yonathan Freund, MD, PhD, of Hôpital Pitié-Salpêtrière. “Whether an adverse event resulted from a misdiagnosis or from the implementation of an inappropriate plan for the correct diagnosis could not be determined decisively. This included sepsis-associated medical errors, which may be particularly relevant, because the most commonly occurring serious adverse events were violations of the surviving sepsis campaign guidelines.”
An adverse event is defined as a preventable or non-preventable injury that was caused by medical management (rather than the underlying disease) and that prolonged hospitalization, produced a disability at the time of discharge, or both. Adverse event also include errors, defined as acts of commission or omission leading to an undesirable outcome or significant potential for such an outcome, and near misses, in which an error was committed, but the patient did not experience clinical harm, either through early detection or sheer luck.
Related Links:
Sorbonne University
Pitie-Salpetriere Hospital
Latest Critical Care News
- AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
- Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
- Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
- New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
- Living Implant Could End Daily Insulin Injections
- Intelligent Camera System Continuously Monitors Premature Babies in NICU
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
- Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
- Imaging Technology Detects Early Signs of Cardiovascular Risk Through Skin
Channels
Artificial Intelligence
view channelSurgical Techniques
view channel
Neural Device Regrows Surrounding Skull After Brain Implantation
Placing electronic implants on the brain typically requires removing a portion of the skull, creating challenges for long-term access and safe closure. Current methods often involve temporarily replacing... Read more
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







